Applications of plant-derived extracellular vesicles in medicine

Abstract

Plant-derived extracellular vesicles (EVs) are promising therapeutic agents owing to their natural abundance, accessibility, and unique biological properties. This review provides a comprehensive exploration of the therapeutic potential of plant-derived EVs and emphasizes their anti-inflammatory, antimicrobial, and tumor-inhibitory effects. Here, we discussed the advancements in isolation and purification techniques, such as ultracentrifugation and size-exclusion chromatography, which are critical for maintaining the functional integrity of these nanovesicles. Next, we investigated the diverse administration routes of EVs and carefully weighed their respective advantages and challenges related to bioavailability and patient compliance. Moreover, we elucidated the multifaceted mechanisms of action of plant-derived EVs, including their roles in anti-inflammation, antioxidation, antitumor activity, and modulation of gut microbiota. We also discussed the impact of EVs on specific diseases such as cancer and inflammatory bowel disease, highlighting the importance of addressing current challenges related to production scalability, regulatory compliance, and immunogenicity. Finally, we proposed future research directions for optimizing EV extraction and developing targeted delivery systems. Through these efforts, we envision the seamless integration of plant-derived EVs into mainstream medicine, offering safe and potent therapeutic alternatives across various medical disciplines.

Keywords

biomedical application / clinical treatment / delivery strategy / extracellular vesicles / plant

References

[1] Yue M, Hu S, Sun H, et al. Extracellular vesicles remodel tumor environment for cancer immunotherapy. Mol Cancer. 2023; 22(1): 203.

[2] Kumar MA, Baba SK, Sadida HQ, et al. Extracellular vesicles as tools and targets in therapy for diseases. Signal Transduct Target Ther. 2024; 9(1): 27.

[3] Cao M, Diao N, Cai X, et al. Plant exosome nanovesicles (PENs): green delivery platforms. Mater Horiz. 2023; 10(10): 3879-3894.

[4] Cong M, Tan S, Li S, et al. Technology insight: plant-derived vesicles-How far from the clinical biotherapeutics and therapeutic drug carriers?. Adv Drug Deliv Rev. 2022; 182: 114108.

[5] Laffin LJ, Bruemmer D, Garcia M, et al. Comparative effects of low-dose rosuvastatin, placebo, and dietary supplements on lipids and inflammatory biomarkers. J Am Coll Cardiol. 2023; 81(1): 1-12.

[6] Michener HD. Effects of ethylene on plant growth hormone. Science. 1935; 82(2136): 551-552.

[7] Miller LH, Ackerman HC, Su XZ, Wellems TE. Malaria biology and disease pathogenesis: insights for new treatments. Nat Med. 2013; 19(2): 156-167.

[8] Wang W, Yang S, Su Y, et al. Enhanced antitumor effect of combined triptolide and ionizing radiation. Clin Cancer Res. 2007; 13(16): 4891-4899.

[9] Shah R, Patel T, Freedman JE. Circulating extracellular vesicles in human disease. N Engl J Med. 2018; 379(10): 958-966.

[10] Zhang S, Wang Q, Tan DEL, et al. Gut-liver axis: potential mechanisms of action of food-derived extracellular vesicles. J Extracell Vesicles. 2024; 13(6): e12466.

[11] Li A, Li D, Gu Y, et al. Plant-derived nanovesicles: further exploration of biomedical function and application potential. Acta Pharm Sin B. 2023; 13(8): 3300-3320.

[12] Robson A. Exosome-derived microRNAs improve cardiac function. Nat Rev Cardiol. 2021; 18(3): 150-151.

[13] Kilchert C, Wittmann S, Vasiljeva L. The regulation and functions of the nuclear RNA exosome complex. Nat Rev Mol Cell Biol. 2016; 17(4): 227-239.

[14] Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020; 367(6478): eaau6977.

[15] Teng Y, Ren Y, Sayed M, et al. Plant-derived exosomal microRNAs shape the gut microbiota. Cell Host Microbe. 2018; 24(5): 637-652.e8.

[16] Teng Y, Xu F, Zhang X, et al. Plant-derived exosomal microRNAs inhibit lung inflammation induced by exosomes SARS-CoV-2 Nsp12. Mol Ther. 2021; 29(8): 2424-2440.

[17] Elkins WL, Guttmann RD. Pathogenesis of a local graft versus host reaction: immunogenicity of circulating host leukocytes. Science. 1968; 159(3820): 1250-1251.

[18] Gunter CJ, Regnard GL, Rybicki EP, Hitzeroth II. Immunogenicity of plant-produced porcine circovirus-like particles in mice. Plant Biotechnol J. 2019; 17(9): 1751-1759.

[19] Zhu L, Sun HT, Wang S, et al. Isolation and characterization of exosomes for cancer research. J Hematol Oncol. 2020; 13(1): 152.

[20] Miron RJ, Zhang Y. Understanding exosomes: part 1-Characterization, quantification and isolation techniques. Periodontol 2000. 2024; 94(1): 231-256.

[21] Perez-Potti A, Rodríguez-Pérez M, Polo E, Pelaz B, Del Pino P. Nanoparticle-based immunotherapeutics: from the properties of nanocores to the differential effects of administration routes. Adv Drug Deliv Rev. 2023; 197: 114829.

[22] Mondal J, Pillarisetti S, Junnuthula V, et al. Hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic applications. J Control Release. 2023; 353: 1127-1149.

[23] Lian MQ, Chng WH, Liang J, et al. Plant-derived extracellular vesicles: recent advancements and current challenges on their use for biomedical applications. J Extracell Vesicles. 2022; 11(12): e12283.

[24] Feng J, Xiu Q, Huang Y, Troyer Z, Li B, Zheng L. Plant-derived vesicle-like nanoparticles as promising biotherapeutic tools: present and future. Adv Mater. 2023; 35(24): e2207826.

[25] Huang Y, Wang S, Cai Q, Jin H. Effective methods for isolation and purification of extracellular vesicles from plants. J Integr Plant Biol. 2021; 63(12): 2020-2030.

[26] You JY, Kang SJ, Rhee WJ. Isolation of cabbage exosome-like nanovesicles and investigation of their biological activities in human cells. Bioact Mater. 2021; 6(12): 4321-4332.

[27] Benmoussa A, Ly S, Shan ST, et al. A subset of extracellular vesicles carries the bulk of microRNAs in commercial dairy cow’s milk. J Extracell Vesicles. 2017; 6(1): 1401897.

[28] Krivitsky V, Krivitsky A, Mantella V, et al. Ultrafast and controlled capturing, loading, and release of extracellular vesicles by a portable microstructured electrochemical fluidic device. Adv Mater. 2023; 35(44): e2212000.

[29] Visan KS, Lobb RJ, Ham S, et al. Comparative analysis of tangential flow filtration and ultracentrifugation, both combined with subsequent size exclusion chromatography, for the isolation of small extracellular vesicles. J Extracell Vesicles. 2022; 11(9): e12266.

[30] Arab T, Raffo-Romero A, Van Camp C, et al. Proteomic characterisation of leech microglia extracellular vesicles (EVs): comparison between differential ultracentrifugation and Optiprep™ density gradient isolation. J Extracell Vesicles. 2019; 8(1): 1603048.

[31] García-Romero N, Madurga R, Rackov G, et al. Polyethylene glycol improves current methods for circulating extracellular vesicle-derived DNA isolation. J Transl Med. 2019; 17(1): 75.

[32] Ludwig AK, De Miroschedji K, Doeppner TR, et al. Precipitation with polyethylene glycol followed by washing and pelleting by ultracentrifugation enriches extracellular vesicles from tissue culture supernatants in small and large scales. J Extracell Vesicles. 2018; 7(1): 1528109.

[33] Wang Z, Ye Q, Yu S, Akhavan B. Poly ethylene glycol (PEG)-based hydrogels for drug delivery in cancer therapy: a comprehensive review. Adv Healthc Mater. 2023; 12(18): e2300105.

[34] Jokhio S, Peng I, Peng CA. Extracellular vesicles isolated from Arabidopsis thaliana leaves reveal characteristics of mammalian exosomes. Protoplasma. 2024;261:1025–1033.

[35] Andreu Z, Rivas E, Sanguino-Pascual A, et al. Comparative analysis of EV isolation procedures for miRNAs detection in serum samples. J Extracell Vesicles. 2016; 5: 31655.

[36] Foers AD, Chatfield S, Dagley LF, et al. Enrichment of extracellular vesicles from human synovial fluid using size exclusion chromatography. J Extracell Vesicles. 2018; 7(1): 1490145.

[37] Oeyen E, Van Mol K, Baggerman G, et al. Ultrafiltration and size exclusion chromatography combined with asymmetrical-flow field-flow fractionation for the isolation and characterisation of extracellular vesicles from urine. J Extracell Vesicles. 2018; 7(1): 1490143.

[38] Kim G, Seo M, Xu J, Park J, Gim S, Chun H. Large-area silicon nitride nanosieve for enhanced diffusion-based exosome isolation. Small Methods. 2024:e2301624.

[39] Chen Y, Zhang Z, Li Z, et al. Dynamic nanomechanical characterization of cells in exosome therapy. Microsyst Nanoeng. 2024; 10: 97.

[40] Lai JJ, Chau ZL, Chen SY, et al. Exosome processing and characterization approaches for research and technology development. Adv Sci (Weinh). 2022; 9(15): e2103222.

[41] Xu Z, Xu Y, Zhang K, et al. Plant-derived extracellular vesicles (PDEVs) in nanomedicine for human disease and therapeutic modalities. J Nanobiotechnology. 2023; 21(1): 114.

[42] Wang X, Xia J, Yang L, Dai J, He L. Recent progress in exosome research: isolation, characterization and clinical applications. Cancer Gene Ther. 2023; 30(8): 1051-1065.

[43] Cao Y, Yu X, Zeng T, et al. Molecular characterization of exosomes for subtype-based diagnosis of breast cancer. J Am Chem Soc. 2022; 144(30): 13475-13486.

[44] Wang F, Gnewou O, Solemanifar A, Conticello VP, Egelman EH. Cryo-EM of helical polymers. Chem Rev. 2022; 122(17): 14055-14065.

[45] Doerr A. A dynamic direction for cryo-EM. Nat Methods. 2022; 19(1): 29.

[46] Zhou S, Hu T, Han G, et al. Accurate cancer diagnosis and stage monitoring enabled by comprehensive profiling of different types of exosomal biomarkers: surface proteins and miRNAs. Small. 2020; 16(48): e2004492.

[47] Barile L, Vassalli G. Exosomes: therapy delivery tools and biomarkers of diseases. Pharmacol Ther. 2017; 174: 63-78.

[48] Hao S, Yang H, Hu J, Luo L, Yuan Y, Liu L. Bioactive compounds and biological functions of medicinal plant-derived extracellular vesicles. Pharmacol Res. 2024; 200: 107062.

[49] Song WY, Wang GL, Chen LL, et al. A receptor kinase-like protein encoded by the rice disease resistance gene, Xa21. Science. 1995; 270(5243): 1804-1806.

[50] Teng Y, He J, Zhong Q, et al. Grape exosome-like nanoparticles: a potential therapeutic strategy for vascular calcification. Front Pharmacol. 2022; 13: 1025768.

[51] Marbán E. The secret life of exosomes: what bees can teach us about next-generation therapeutics. J Am Coll Cardiol. 2018; 71(2): 193-200.

[52] Théry C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002; 2(8): 569-579.

[53] Cunha ERK, Ying W, Olefsky JM. Exosome-mediated impact on systemic metabolism. Annu Rev Physiol. 2024; 86: 225-253.

[54] Huang R, Jia B, Su D, et al. Plant exosomes fused with engineered mesenchymal stem cell-derived nanovesicles for synergistic therapy of autoimmune skin disorders. J Extracell Vesicles. 2023; 12(10): e12361.

[55] Liu J, Sun Y, Zeng X, et al. Engineering and characterization of an artificial drug-carrying vesicles nanoplatform for enhanced specifically targeted therapy of glioblastoma. Adv Mater. 2023; 35(41): e2303660.

[56] Lim GB. Exosome-eluting stents improve vascular remodelling. Nat Rev Cardiol. 2021; 18(6): 386.

[57] Chi J, Sun L, Cai L, et al. Chinese herb microneedle patch for wound healing. Bioact Mater. 2021; 6(10): 3507-3514.

[58] Zhang DY, Cheng YB, Guo QH, et al. Treatment of masked hypertension with a Chinese herbal formula: a randomized, placebo-controlled trial. Circulation. 2020; 142(19): 1821-1830.

[59] Liu Y, Feng N. Nanocarriers for the delivery of active ingredients and fractions extracted from natural products used in traditional Chinese medicine (TCM). Adv Colloid Interface Sci. 2015; 221: 60-76.

[60] Que H, Hong W, Lan T, et al. Tripterin liposome relieves severe acute respiratory syndrome as a potent COVID-19 treatment. Signal Transduct Target Ther. 2022; 7(1): 399.

[61] Xu Z, Fang L, Pan D. Regulate prescription of Chinese medicines. Nature. 2018; 553(7689): 405.

[62] Weng Z, Wei Q, Ye C, et al. Traditional Herb (Moxa) modified zinc oxide nanosheets for quick, efficient and high tissue penetration therapy of fungal infection. ACS Nano. 2024; 18(6): 5180-5195.

[63] Kumar A, Sundaram K, Teng Y, et al. Ginger nanoparticles mediated induction of Foxa2 prevents high-fat diet-induced insulin resistance. Theranostics. 2022; 12(3): 1388-1403.

[64] Li C, Tobi EW, Heijmans BT, Lumey LH. The effect of the Chinese Famine on type 2 diabetes mellitus epidemics. Nat Rev Endocrinol. 2019; 15(6): 313-314.

[65] Haase K, Offeddu GS, Gillrie MR, Kamm RD. Endothelial regulation of drug transport in a 3D vascularized tumor model. Adv Funct Mater. 2020; 30(48).

[66] Eddy MT, Lee MY, Gao ZG, et al. Allosteric coupling of drug binding and intracellular signaling in the A(2A) adenosine receptor. Cell. 2018; 172(1-2): 68-80.e12.

[67] Wang Q, Su CP, Zhang HM, Ren YL, Wang W, Guo SZ. [Anti-inflammatory mechanism of heat-clearing and detoxifying Chinese herbs]. Zhongguo Zhong Yao Za Zhi. 2018; 43(18): 3787-3794.

[68] Zeng X, Chen B, Wang L, et al. Chitosan@Puerarin hydrogel for accelerated wound healing in diabetic subjects by miR-29ab1 mediated inflammatory axis suppression. Bioact Mater. 2023; 19: 653-665.

[69] Puerarin alleviates atherosclerosis via the inhibition of Prevotella copri and its trimethylamine production. Gut. 2024;

[70] Cai H, Huang LY, Hong R, et al. Momordica charantia exosome-like nanoparticles exert neuroprotective effects against ischemic brain injury via inhibiting matrix metalloproteinase 9 and activating the AKT/GSK3β signaling pathway. Front Pharmacol. 2022; 13: 908830.

[71] Zhan W, Deng M, Huang X, et al. Pueraria lobata-derived exosome-like nanovesicles alleviate osteoporosis by enhacning autophagy. J Control Release. 2023; 364: 644-653.

[72] Yang Y, Li H, Wang F, Jiang P, Wang G. An arabinogalactan extracted with alkali from Portulaca oleracea L. used as an immunopotentiator and a vaccine carrier in its conjugate to BSA. Carbohydr Polym. 2023; 316: 120998.

[73] Feng PC, Haynes LJ, Magnus KE. High concentration of (-)-noradrenaline in Portulaca oleracea L. Nature. 1961; 191: 1108.

[74] Jang J, Jeong H, Jang E, et al. Isolation of high-purity and high-stability exosomes from ginseng. Front Plant Sci. 2023; 13.

[75] Zhang L, Liu Y, Zhang Q, et al. Salvia miltiorrhiza polysaccharide mitigates AFB1-induced liver injury in rabbits. Ecotoxicol Environ Safety. 2024; 276.

[76] Zhu M-Z, Xu H-M, Liang Y-J, et al. Edible exosome-like nanoparticles from portulaca oleracea L mitigate DSS-induced colitis via facilitating double-positive CD4+CD8+T cells expansion. J Nanobiotechnol. 2023; 21(1): 309.

[77] Jang S, Lee M-S, Kang S-A, Kim C-T, Kim Y. Portulaca oleracea L. extract regulates hepatic cholesterol metabolism via the AMPK/MicroRNA-33/34a pathway in rats fed a high-cholesterol diet. Nutrients. 2022; 14(16).

[78] Zhu H, Chang M, Wang Q, Chen J, Liu D, He W. Identifying the potential of miRNAs in Houttuynia cordata-derived exosome-like nanoparticles against respiratory RNA viruses. Int J Nanomed. 2023; 18: 5983-6000.

[79] Bhatia IS, Ullah R. Metabolism of polyphenols in the tea leaf. Nature. 1962; 193: 658-659.

[80] Chen Q, Zu M, Gong H, et al. Tea leaf-derived exosome-like nanotherapeutics retard breast tumor growth by pro-apoptosis and microbiota modulation. J Nanobiotechnology. 2023; 21(1): 6.

[81] Gao Q, Chen N, Li B, et al. Natural lipid nanoparticles extracted from Morus nigra L. leaves for targeted treatment of hepatocellular carcinoma via the oral route. J Nanobiotechnology. 2024; 22(1): 4.

[82] He C, Wang K, Xia J, et al. Natural exosomes-like nanoparticles in mung bean sprouts possesses anti-diabetic effects via activation of PI3K/Akt/GLUT4/GSK-3β signaling pathway. J Nanobiotechnology. 2023; 21(1): 349.

[83] McHugh J. Modifying exosomes to target macrophages in arthritis. Nat Rev Rheumatol. 2021; 17(8): 443.

[84] Koppers-Lalic D, Hogenboom MM, Middeldorp JM, Pegtel DM. Virus-modified exosomes for targeted RNA delivery; a new approach in nanomedicine. Adv Drug Deliv Rev. 2013; 65(3): 348-356.

[85] Ke W, Afonin KA. Exosomes as natural delivery carriers for programmable therapeutic nucleic acid nanoparticles (NANPs). Adv Drug Deliv Rev. 2021; 176: 113835.

[86] Kamerkar S, LeBleu VS, Sugimoto H, et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature. 2017; 546(7659): 498-503.

[87] Perrier DL, Rems L, Boukany PE. Lipid vesicles in pulsed electric fields: fundamental principles of the membrane response and its biomedical applications. Adv Colloid Interface Sci. 2017; 249: 248-271.

[88] Richter M, Vader P, Fuhrmann G. Approaches to surface engineering of extracellular vesicles. Adv Drug Deliv Rev. 2021; 173: 416-426.

[89] Esmaeili A, Hosseini S, Baghaban Eslaminejad M. Co-culture engineering: a promising strategy for production of engineered extracellular vesicle for osteoarthritis treatment. Cell Commun Signal. 2024; 22(1): 29.

[90] Lara P, Huis In ’t Veld RV, Jorquera-Cordero C, Chan AB, Ossendorp F, Cruz LJ. Zinc-phthalocyanine-loaded extracellular vesicles increase efficacy and selectivity of photodynamic therapy in co-culture and preclinical models of colon cancer. Pharmaceutics. 2021; 13(10): 1547.

[91] Haney MJ, Klyachko NL, Zhao Y, et al. Exosomes as drug delivery vehicles for Parkinson’s disease therapy. J Control Release. 2015; 207: 18-30.

[92] Ter-Ovanesyan D, Norman M, Lazarovits R, et al. Framework for rapid comparison of extracellular vesicle isolation methods. Elife. 2021; 10: e70725.

[93] Li Y, Xing L, Wang L, et al. Milk-derived exosomes as a promising vehicle for oral delivery of hydrophilic biomacromolecule drugs. Asian J Pharm Sci. 2023; 18(2): 100797.

[94] Bost JP, Barriga H, Holme MN, et al. Delivery of oligonucleotide therapeutics: chemical modifications, lipid nanoparticles, and extracellular vesicles. ACS Nano. 2021; 15(9): 13993-14021.

[95] Mohammadi AH, Ghazvinian Z, Bagheri F, Harada M, Baghaei K. Modification of extracellular vesicle surfaces: an approach for targeted drug delivery. BioDrugs. 2023; 37(3): 353-374.

[96] Tian T, Zhang HX, He CP, et al. Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy. Biomaterials. 2018; 150: 137-149.

[97] Dad HA, Gu TW, Zhu AQ, Huang LQ, Peng LH. Plant exosome-like nanovesicles: emerging therapeutics and drug delivery nanoplatforms. Mol Ther. 2021; 29(1): 13-31.

[98] Jiang D, Li Z, Liu H, Liu H, Xia X, Xiang X. Plant exosome-like nanovesicles derived from sesame leaves as carriers for luteolin delivery: molecular docking, stability and bioactivity. Food Chem. 2024; 438: 137963.

[99] Schulz-Siegmund M, Aigner A. Nucleic acid delivery with extracellular vesicles. Adv Drug Deliv Rev. 2021; 173: 89-111.

[100] Lin SW, Tsai JC, Shyong YJ. Drug delivery of extracellular vesicles: preparation, delivery strategies and applications. Int J Pharm. 2023; 642: 123185.

[101] Manickam DS. Delivery of mitochondria via extracellular vesicles—a new horizon in drug delivery. J Control Release. 2022; 343: 400-407.

[102] Lin JR, Ding LL, Xu L, et al. Brown adipocyte ADRB3 mediates cardioprotection via suppressing exosomal iNOS. Circ Res. 2022; 131(2): 133-147.

[103] Xie Z, Gao Y, Ho C, et al. Exosome-delivered CD44v6/C1QBP complex drives pancreatic cancer liver metastasis by promoting fibrotic liver microenvironment. Gut. 2022; 71(3): 568-579.

[104] Wu C, Xiang S, Wang H, et al. Orally deliverable sequence-targeted fucoxanthin-loaded biomimetic extracellular vesicles for alleviation of nonalcoholic fatty liver disease. ACS Appl Mater Interfaces. 2024; 16(8): 9854-9867.

[105] Gupta D, Zickler AM, El Andaloussi S. Dosing extracellular vesicles. Adv Drug Deliv Rev. 2021; 178: 113961.

[106] Donoso-Meneses D, Figueroa-Valdés AI, Khoury M, Alcayaga-Miranda F. Oral administration as a potential alternative for the delivery of small extracellular vesicles. Pharmaceutics. 2023; 15(3): 716.

[107] Rahmati S, Khazaei M, Abpeikar Z, Soleimanizadeh A, Rezakhani L. Exosome-loaded decellularized tissue: opening a new window for regenerative medicine. J Tissue Viability. 2024; 33(2): 332-344.

[108] Ai X, Yang J, Liu Z, Guo T, Feng N. Recent progress of microneedles in transdermal immunotherapy: a review. Int J Pharm. 2024; 662: 124481.

[109] Lin Y, Yan M, Bai Z, et al. Huc-MSC-derived exosomes modified with the targeting peptide of aHSCs for liver fibrosis therapy. J Nanobiotechnol. 2022; 20(1): 432.

[110] Ran N, Li W, Zhang R, et al. Autologous exosome facilitates load and target delivery of bioactive peptides to repair spinal cord injury. Bioact Mater. 2023; 25: 766-782.

[111] Deng S, Cao H, Cui X, Fan Y, Wang Q, Zhang X. Optimization of exosome-based cell-free strategies to enhance endogenous cell functions in tissue regeneration. Acta Biomater. 2023; 171: 68-84.

[112] Li Z, Zhao P, Zhang Y, et al. Exosome-based Ldlr gene therapy for familial hypercholesterolemia in a mouse model. Theranostics. 2021; 11(6): 2953-2965.

[113] Smyth T, Kullberg M, Malik N, Smith-Jones P, Graner MW, Anchordoquy TJ. Biodistribution and delivery efficiency of unmodified tumor-derived exosomes. J Control Release. 2015; 199: 145-155.

[114] Li Z, Wang H, Yin H, Bennett C, Zhang HG, Guo P. Arrowtail RNA for ligand display on ginger exosome-like nanovesicles to systemic deliver siRNA for cancer suppression. Sci Rep. 2018; 8(1): 14644.

[115] Li Y, Hu C, Zhai P, et al. Fibroblastic reticular cell-derived exosomes are a promising therapeutic approach for septic acute kidney injury. Kidney Int. 2024; 105(3): 508-523.

[116] Cai J, Tang D, Hao X, Liu E, Li W, Shi J. Mesenchymal stem cell-derived exosome alleviates sepsis-associated acute liver injury by suppressing MALAT1 through microRNA-26a-5p: an innovative immunopharmacological intervention and therapeutic approach for sepsis. Front Immunol. 2023; 14: 1157793.

[117] Grossen P, Portmann M, Koller E, et al. Evaluation of bovine milk extracellular vesicles for the delivery of locked nucleic acid antisense oligonucleotides. Eur J Pharm Biopharm. 2021; 158: 198-210.

[118] Kumar A, Ren Y, Sundaram K, et al. miR-375 prevents high-fat diet-induced insulin resistance and obesity by targeting the aryl hydrocarbon receptor and bacterial tryptophanase (tnaA) gene. Theranostics. 2021; 11(9): 4061-4077.

[119] Zu M, Liu G, Chen N, et al. Oral exosome-like nanovesicles from Phellinus linteus suppress metastatic hepatocellular carcinoma by reactive oxygen species generation and microbiota rebalancing. Nanoscale. 2024; 16(16): 8046-8059.

[120] Eii MN, Walpole S, Aldridge C. Sustainable practice: prescribing oral over intravenous medications. Bmj. 2023; 383: e075297.

[121] Ou X, Wang H, Tie H, et al. Novel plant-derived exosome-like nanovesicles from Catharanthus roseus: preparation, characterization, and immunostimulatory effect via TNF-α/NF-κB/PU.1 axis. J Nanobiotechnology. 2023; 21(1): 160.

[122] Miettinen K, Dong L, Navrot N, et al. The seco-iridoid pathway from Catharanthus roseus. Nat Commun. 2014; 5: 3606.

[123] Xia D, Wood-Yang AJ, Prausnitz MR. Clearing away barriers to oral drug delivery. Sci Robot. 2022; 7(70): eade3311.

[124] Drucker DJ. Advances in oral peptide therapeutics. Nat Rev Drug Discov. 2020; 19(4): 277-289.

[125] Park K-S, Svennerholm K, Shelke GV, et al. Mesenchymal stromal cell-derived nanovesicles ameliorate bacterial outer membrane vesicle-induced sepsis via IL-10. Stem Cell Res Ther. 2019; 10(1): 231.

[126] Sharma S, Masud MK, Kaneti YV, et al. Extracellular vesicle nanoarchitectonics for novel drug delivery applications. Small. 2021; 17(42): e2102220.

[127] Dasgupta D, Nakao Y, Mauer AS, et al. IRE1A stimulates hepatocyte-derived extracellular vesicles that promote inflammation in mice with steatohepatitis. Gastroenterology. 2020; 159(4): 1487-1503.e17.

[128] Heidari N, Abbasi-Kenarsari H, Namaki S, et al. Adipose-derived mesenchymal stem cell-secreted exosome alleviates dextran sulfate sodium-induced acute colitis by Treg cell induction and inflammatory cytokine reduction. J Cell Physiol. 2021; 236(8): 5906-5920.

[129] Ashour AA, El-Kamel AH, Mehanna RA, Mourad G, Heikal Lamia A. Luteolin-loaded exosomes derived from bone marrow mesenchymal stem cells: a promising therapy for liver fibrosis. Drug Deliv. 2022; 29(1): 3270-3280.

[130] Li Z, Du Y, Lu Y, et al. Hypericum perforatum-derived exosomes-like nanovesicles for adipose tissue photodynamic therapy. Phytomedicine. 2024; 132: 155854.

[131] Wang J, Ghosh D, Maniruzzaman M. Using bugs as drugs: administration of bacteria-related microbes to fight cancer. Adv Drug Deliv Rev. 2023; 197: 114825.

[132] Muntjewerff EM, Christoffersson G, Mahata SK, van den Bogaart G. Putative regulation of macrophage-mediated inflammation by catestatin. Trends Immunol. 2022; 43(1): 41-50.

[133] You LN, Tai QW, Xu L, et al. Exosomal LINC00161 promotes angiogenesis and metastasis via regulating miR-590-3p/ROCK axis in hepatocellular carcinoma. Cancer Gene Ther. 2021; 28(6): 719-736.

[134] Xie Z, Wang X, Liu X, et al. Adipose-derived exosomes exert proatherogenic effects by regulating macrophage foam cell formation and polarization. J Am Heart Assoc. 2018; 7(5): e007442.

[135] Bo Y, Yang L, Liu B, et al. Exosomes from human induced pluripotent stem cells-derived keratinocytes accelerate burn wound healing through miR-762 mediated promotion of keratinocytes and endothelial cells migration. J Nanobiotechnology. 2022; 20(1): 291.

[136] Zheng F, Hou P, Corpstein CD, Park K, Li T. Multiscale pharmacokinetic modeling of systemic exposure of subcutaneously injected biotherapeutics. J Control Release. 2021; 337: 407-416.

[137] Del Pozo-Acebo L, López de Las Hazas MC, Tomé-Carneiro J, et al. Therapeutic potential of broccoli-derived extracellular vesicles as nanocarriers of exogenous miRNAs. Pharmacol Res. 2022; 185: 106472.

[138] Sundaram K, Mu J, Kumar A, et al. Garlic exosome-like nanoparticles reverse high-fat diet induced obesity via the gut/brain axis. Theranostics. 2022; 12(3): 1220-1246.

[139] Sundaram K, Teng Y, Mu J, et al. Outer membrane vesicles released from garlic exosome-like nanoparticles (GaELNs) train gut bacteria that reverses type 2 diabetes via the gut-brain axis. Small. 2024; 20(20): e2308680.

[140] Lei C, Teng Y, He L, et al. Lemon exosome-like nanoparticles enhance stress survival of gut bacteria by RNase P-mediated specific tRNA decay. iScience. 2021; 24(6): 102511.

[141] Dolivo D, Weathers P, Dominko T. Artemisinin and artemisinin derivatives as anti-fibrotic therapeutics. Acta Pharm Sin B. 2021; 11(2): 322-339.

[142] Tang TT, Wang B, Lv LL, Liu BC. Extracellular vesicle-based nanotherapeutics: emerging frontiers in anti-inflammatory therapy. Theranostics. 2020; 10(18): 8111-8129.

[143] Wang C, Wang M, Xia K, et al. A bioactive injectable self-healing anti-inflammatory hydrogel with ultralong extracellular vesicles release synergistically enhances motor functional recovery of spinal cord injury. Bioact Mater. 2021; 6(8): 2523-2534.

[144] Auger JP, Zimmermann M, Faas M, et al. Metabolic rewiring promotes anti-inflammatory effects of glucocorticoids. Nature. 2024; 629(8010): 184-192.

[145] Wu J, Ma X, Lu Y, et al. Edible Pueraria lobata-derived exosomes promote M2 macrophage polarization. Molecules. 2022; 27(23): 8184.

[146] Zhang W, Song Q, Bi X, et al. Preparation of Pueraria lobata root-derived exosome-like nanovesicles and evaluation of their effects on mitigating alcoholic intoxication and promoting alcohol metabolism in mice. Int J Nanomedicine. 2024; 19: 4907-4921.

[147] Luo Q, Xian P, Wang T, et al. Antioxidant activity of mesenchymal stem cell-derived extracellular vesicles restores hippocampal neurons following seizure damage. Theranostics. 2021; 11(12): 5986-6005.

[148] Lisi V, Senesi G, Bertola N, et al. Plasma-derived extracellular vesicles released after endurance exercise exert cardioprotective activity through the activation of antioxidant pathways. Redox Biol. 2023; 63: 102737.

[149] Hwang JH, Park YS, Kim HS, et al. Yam-derived exosome-like nanovesicles stimulate osteoblast formation and prevent osteoporosis in mice. J Control Release. 2023; 355: 184-198.

[150] Louro AF, Meliciano A, Alves PM, Costa MHG, Serra M. A roadmap towards manufacturing extracellular vesicles for cardiac repair. Trends Biotechnol. 2024.

[151] Kim DK, Rhee WJ. Antioxidative effects of carrot-derived nanovesicles in cardiomyoblast and neuroblastoma cells. Pharmaceutics. 2021; 13(8): 1203.

[152] Nguyen TN, Pham CV, Chowdhury R, et al. Development of blueberry-derived extracellular nanovesicles for immunomodulatory therapy. Pharmaceutics. 2023; 15(8): 2115.

[153] Chen P, Wang L, Fan X, et al. Targeted delivery of extracellular vesicles in heart injury. Theranostics. 2021; 11(5): 2263-2277.

[154] Witwer KW, Wolfram J. Extracellular vesicles versus synthetic nanoparticles for drug delivery. Nat Rev Mater. 2021; 6(2): 103-106.

[155] Vergani E, Daveri E, Vallacchi V, et al. Extracellular vesicles in anti-tumor immunity. Semin Cancer Biol. 2022; 86(1): 64-79. Pt.

[156] Wang X, Zhang Y, Chung Y, et al. Tumor vaccine based on extracellular vesicles derived from γδ-T cells exerts dual antitumor activities. J Extracell Vesicles. 2023; 12(9): e12360.

[157] Liu JJ, Tang W, Fu M, et al. Development of R(8) modified epirubicin-dihydroartemisinin liposomes for treatment of non-small-cell lung cancer. Artif Cells Nanomed Biotechnol. 2019; 47(1): 1947-1960.

[158] Huang J, Cao X, Wu W, Han L, Wang F. Investigating the proliferative inhibition of HepG2 cells by exosome-like nanovesicles derived from Centella asiatica extract through metabolomics. Biomed Pharmacother. 2024; 176: 116855.

[159] Kim W, Lee EJ, Bae IH, et al. Lactobacillus plantarum-derived extracellular vesicles induce anti-inflammatory M2 macrophage polarization in vitro. J Extracell Vesicles. 2020; 9(1): 1793514.

[160] Li H, Zhao S, Jiang M, et al. Biomodified extracellular vesicles remodel the intestinal microenvironment to overcome radiation enteritis. ACS Nano. 2023; 17(14): 14079-14098.

[161] Qiu FS, Wang JF, Guo MY, et al. Rgl-exomiR-7972, a novel plant exosomal microRNA derived from fresh Rehmanniae Radix, ameliorated lipopolysaccharide-induced acute lung injury and gut dysbiosis. Biomed Pharmacother. 2023; 165: 115007.

[162] Cui Z, Amevor FK, Zhao X, et al. Potential therapeutic effects of milk-derived exosomes on intestinal diseases. J Nanobiotechnology. 2023; 21(1): 496.

[163] Pang W, Zuo Z, Sun W, et al. Kidney bean derived exosome-like nanovesicles ameliorate high-fat diet-induced obesity via reshaping gut microbiota. J Funct Foods. 2024; 113: 105997.

[164] Wicaksono WA, Cernava T, Wassermann B, et al. The edible plant microbiome: evidence for the occurrence of fruit and vegetable bacteria in the human gut. Gut Microbes. 2023; 15(2): 2258565.

[165] Duan T, Wang X, Dong X, et al. Broccoli-derived exosome-like nanoparticles alleviate loperamide-induced constipation, in correlation with regulation on gut microbiota and tryptophan metabolism. J Agric Food Chem. 2023; 71(44): 16568-16580.

[166] Conlan RS, Pisano S, Oliveira MI, Ferrari M, Mendes Pinto I. Exosomes as reconfigurable therapeutic systems. Trends Mol Med. 2017; 23(7): 636-650.

[167] Ni Z, Zhou S, Li S, et al. Exosomes: roles and therapeutic potential in osteoarthritis. Bone Res. 2020; 8: 25.

[168] Kim M, Park JH. Isolation of Aloe saponaria-derived extracellular vesicles and investigation of their potential for chronic wound healing. Pharmaceutics. 2022; 14(9): 1905.

[169] Shao M, Jin X, Chen S, Yang N, Feng G. Plant-derived extracellular vesicles—a novel clinical anti-inflammatory drug carrier worthy of investigation. Biomed Pharmacother. 2023; 169: 115904.

[170] Wang Q, Zhuang X, Mu J, et al. Delivery of therapeutic agents by nanoparticles made of grapefruit-derived lipids. Nat Commun. 2013; 4: 1867.

[171] Farran B, Nagaraju GP. Exosomes as therapeutic solutions for pancreatic cancer. Drug Discov Today. 2020; 25(12): 2245-2256.

[172] Zhang L, He F, Gao L, et al. Engineering exosome-like nanovesicles derived from asparagus cochinchinensis can inhibit the proliferation of hepatocellular carcinoma cells with better safety profile. Int J Nanomedicine. 2021; 16: 1575-1586.

[173] Yan G, Xiao Q, Zhao J, et al. Brucea javanica derived exosome-like nanovesicles deliver miRNAs for cancer therapy. J Control Release. 2024; 367: 425-440.

[174] Kim J, Zhu Y, Chen S, et al. Anti-glioma effect of ginseng-derived exosomes-like nanoparticles by active blood-brain-barrier penetration and tumor microenvironment modulation. J Nanobiotechnology. 2023; 21(1): 253.

[175] Liu C, Yan X, Zhang Y, et al. Oral administration of turmeric-derived exosome-like nanovesicles with anti-inflammatory and pro-resolving bioactions for murine colitis therapy. J Nanobiotechnology. 2022; 20(1): 206.

[176] Wang Q, Liu K, Cao X, et al. Plant-derived exosomes extracted from Lycium barbarum L. loaded with isoliquiritigenin to promote spinal cord injury repair based on 3D printed bionic scaffold. Bioeng Transl Med. 2024; 9(4): e10646.

[177] Li J, Wu H, Yu Z, et al. Hematopoietic stem and progenitor cell membrane-coated vesicles for bone marrow-targeted leukaemia drug delivery. Nat Commun. 2024; 15(1): 5689.

[178] Tang J, Chen Y, Wang C, et al. The role of mesenchymal stem cells in cancer and prospects for their use in cancer therapeutics. MedComm. 2024; 5(8): e663.

[179] Su X, Shan Z, Duan S. Harnessing extracellular vesicles using liquid biopsy for cancer diagnosis and monitoring: highlights from AACR Annual Meeting 2024. J Hematol Oncol. 2024; 17(1): 55.

[180] Chen X, Ji S, Yan Y, et al. Engineered plant-derived nanovesicles facilitate tumor therapy: natural bioactivity plus drug controlled release platform. Int J Nanomedicine. 2023; 18: 4779-4804.

[181] Cheng X, Henick BS, Cheng K. Anticancer therapy targeting cancer-derived extracellular vesicles. ACS Nano. 2024; 18(9): 6748-6765.

[182] Cathcart P, Stebbing J. Aloe vera, a natural cancer soother?. Lancet Oncol. 2016; 17(4): 421.

[183] Ushasree MV, Jia Q, Do SG, Lee EY. New opportunities and perspectives on biosynthesis and bioactivities of secondary metabolites from Aloe vera. Biotechnol Adv. 2024; 72: 108325.

[184] Zhang M, Liu Q, Meng H, et al. Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets. Signal Transduct Target Ther. 2024; 9(1): 12.

[185] Figueroa-Juárez E. Uncovering the origin of oxidative damage in ischaemia-reperfusion injury in the heart. Nat Rev Endocrinol. 2023; 19(10): 560.

[186] Chen X, Chen H, Zhu L, et al. Nanoparticle-patch system for localized, effective, and sustained miRNA administration into infarcted myocardium to alleviate myocardial ischemia-reperfusion injury. ACS Nano. 2024.

[187] Zhang B, Shi H, Xu J, et al. Adnexal tumor found during a brain-dead donor organ retrieval: a case report*. Oncol Transl Med. 2022; 8(6): 314-317.

[188] Ma W, Wu D, Long C, et al. Neutrophil-derived nanovesicles deliver IL-37 to mitigate renal ischemia-reperfusion injury via endothelial cell targeting. J Control Release. 2024; 370: 66-81.

[189] Lu T, Zhang J, Cai J, et al. Extracellular vesicles derived from mesenchymal stromal cells as nanotherapeutics for liver ischaemia-reperfusion injury by transferring mitochondria to modulate the formation of neutrophil extracellular traps. Biomaterials. 2022; 284: 121486.

[190] Lu X, Xu Z, Shu F, et al. Reactive oxygen species responsive multifunctional fusion extracellular nanovesicles: prospective treatments for acute heart transplant rejection. Adv Mater. 2024; 36: e2406758.

[191] Ding S, Kim YJ, Huang KY, Um D, Jung Y, Kong H. Delivery-mediated exosomal therapeutics in ischemia-reperfusion injury: advances, mechanisms, and future directions. Nano Converg. 2024; 11(1): 18.

[192] Li S, Zhang R, Wang A, et al. Panax notoginseng: derived exosome-like nanoparticles attenuate ischemia reperfusion injury via altering microglia polarization. J Nanobiotechnology. 2023; 21(1): 416.

[193] Lai J, Pan Q, Chen G, et al. Triple hybrid cellular nanovesicles promote cardiac repair after ischemic reperfusion. ACS Nano. 2024; 18(5): 4443-4455.

[194] Xiong Y, Lin Z, Bu P, et al. A whole-course-repair system based on neurogenesis-angiogenesis crosstalk and macrophage reprogramming promotes diabetic wound healing. Adv Mater. 2023; 35(19): e2212300.

[195] Zhang Y, Li M, Wang Y, et al. Exosome/metformin-loaded self-healing conductive hydrogel rescues microvascular dysfunction and promotes chronic diabetic wound healing by inhibiting mitochondrial fission. Bioact Mater. 2023; 26: 323-336.

[196] Prasai A, Jay JW, Jupiter D, Wolf SE, El Ayadi A. Role of exosomes in dermal wound healing: a systematic review. J Invest Dermatol. 2022; 142(3): 662-678.e8. Pt A.

[197] Atwood RE, Bradley MJ, Elster EA. Use of negative pressure wound therapy on conflict-related wounds. Lancet Glob Health. 2020; 8(3): e319-e320.

[198] Yu F, Zhao X, Wang Q, et al. Engineered mesenchymal stromal cell exosomes-loaded microneedles improve corneal healing after chemical injury. ACS Nano. 2024.

[199] Tan M, Liu Y, Xu Y, et al. Plant-Derived Exosomes as Novel Nanotherapeutics Contrive Glycolysis Reprogramming-Mediated Angiogenesis for Diabetic Ulcer Healing. Biomater Res. 2024; 28: 0035.

[200] Kim YS, Cho IH, Jeong MJ, et al. Therapeutic effect of total ginseng saponin on skin wound healing. J Ginseng Res. 2011; 35(3): 360-367.

[201] Qiao Z, Wang X, Zhao H, et al. The effectiveness of cell-derived exosome therapy for diabetic wound: a systematic review and meta-analysis. Ageing Res Rev. 2023; 85: 101858.

[202] Deng C, Hu Y, Conceição M, et al. Oral delivery of layer-by-layer coated exosomes for colitis therapy. J Control Release. 2023; 354: 635-650.

[203] Zhu H, Chang M, Wang Q, Chen J, Liu D, He W. Identifying the potential of miRNAs in Houttuynia cordata-derived exosome-like nanoparticles against respiratory RNA viruses. Int J Nanomedicine. 2023; 18: 5983-6000.

[204] Zu M, Liu G, Xu H, et al. Extracellular vesicles from nanomedicine-trained intestinal microbiota substitute for fecal microbiota transplant in treating ulcerative colitis. Adv Mater. 2024:e2409138.

[205] Ou Z, Situ B, Huang X, et al. Single-particle analysis of circulating bacterial extracellular vesicles reveals their biogenesis, changes in blood and links to intestinal barrier. J Extracell Vesicles. 2023; 12(12): e12395.

[206] Lin G, Zheng X, Wang F, Xing D, Cao Y. Primary malignant melanoma of the esophagus successfully treated with camrelizumab: a case report and literature review*. Oncol Transl Med. 2022; 8(4): 201-208.

[207] Yang S, Li W, Bai X, et al. Ginseng-derived nanoparticles alleviate inflammatory bowel disease via the TLR4/MAPK and p62/Nrf2/Keap1 pathways. J Nanobiotechnology. 2024; 22(1): 48.

[208] Huang H, Davis CD, Wang TTY. Extensive degradation and low bioavailability of orally consumed corn miRNAs in mice. Nutrients. 2018; 10(2): 215.

[209] Wei X, Li X, Zhang Y, Wang J, Shen S. Advances in the therapeutic applications of plant-derived exosomes in the treatment of inflammatory diseases. Biomedicines. 2023; 11(6): 1554.

[210] Liu C, Yazdani N, Moran CS, et al. Unveiling clinical applications of bacterial extracellular vesicles as natural nanomaterials in disease diagnosis and therapeutics. Acta Biomater. 2024; 180: 18-45.

[211] Ocansey DKW, Zhang L, Wang Y, et al. Exosome-mediated effects and applications in inflammatory bowel disease. Biol Rev Camb Philos Soc. 2020; 95(5): 1287-1307.

[212] Zhang H, Wang L, Li C, et al. Exosome-induced regulation in inflammatory bowel disease. Front Immunol. 2019; 10: 1464.

[213] Gao C, Zhou Y, Chen Z, et al. Turmeric-derived nanovesicles as novel nanobiologics for targeted therapy of ulcerative colitis. Theranostics. 2022; 12(12): 5596-5614.

[214] Trenkenschuh E, Richter M, Heinrich E, Koch M, Fuhrmann G, Friess W. Enhancing the stabilization potential of lyophilization for extracellular vesicles. Adv Healthc Mater. 2022; 11(5): e2100538.

[215] Li D, Yao X, Yue J, et al. Advances in bioactivity of microRNAs of plant-derived exosome-like nanoparticles and milk-derived extracellular vesicles. J Agric Food Chem. 2022; 70(21): 6285-6299.

[216] van Niel G, D’Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018; 19(4): 213-228.

[217] Liu C, Sun G, Wang H, Shang G, Yan X, Zou X. Analysis of the intestinal flora in patients with primary liver cancer*. Oncol Transl Med. 2023; 9(1): 28-34.

[218] Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007; 9(6): 654-659.

[219] Gong J, Zhang X, Khan A, et al. Identification of serum exosomal miRNA biomarkers for diagnosis of rheumatoid arthritis. Int Immunopharmacol. 2024; 129: 111604.

[220] Li J, Long Q, Ding H, et al. Progress in the treatment of central nervous system diseases based on nanosized traditional Chinese medicine. Adv Sci (Weinh). 2024; 11(16): e2308677.

[221] Li K, Ma X, Li Z, et al. A natural peptide from a traditional Chinese medicine has the potential to treat chronic atrophic gastritis by activating gastric stem cells. Adv Sci (Weinh). 2024; 11(20): e2304326.

[222] Ren HZ, Xia SZ, Qin XQ, Hu AY, Wang JL. FOXO1 alleviates liver ischemia-reperfusion injury by regulating the Th17/Treg ratio through the AKT/Stat3/FOXO1 pathway. J Clin Transl Hepatol. 2022; 10(6): 1138-1147.

[223] Davda J, Declerck P, Hu-Lieskovan S, et al. Immunogenicity of immunomodulatory, antibody-based, oncology therapeutics. J Immunother Cancer. 2019; 7(1): 105.

[224] Wang J, Ding H, Zhou J, Xia S, Shi X, Ren H. Transplantation of mesenchymal stem cells attenuates acute liver failure in mice via an interleukin-4-dependent switch to the M2 macrophage anti-inflammatory phenotype. J Clin Transl Hepatol. 2022; 10(4): 669-679.

[225] Ma X, Yang R, Li H, Zhang X, Zhang X, Li X. Role of exosomes in the communication and treatment between OSCC and normal cells. Heliyon. 2024; 10(7): e28148.

[226] Pan W, Xu X, Zhang M, Song X. Human urine-derived stem cell-derived exosomal miR-21-5p promotes neurogenesis to attenuate Rett syndrome via the EPha4/TEK axis. Lab Invest. 2021; 101(7): 824-836.

[227] Rayyan M, Zheutlin A, Byrd JB. Clinical research using extracellular vesicles: insights from the International Society for Extracellular Vesicles 2018 Annual Meeting. J Extracell Vesicles. 2018; 7(1): 1535744.

[228] Wang X, He B. Insight into endothelial cell-derived extracellular vesicles in cardiovascular disease: molecular mechanisms and clinical implications. Pharmacol Res. 2024; 207: 107309.

RIGHTS & PERMISSIONS

2024 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.